Prophylaxis and Treatment of NSAID-Induced Gastroduodenal Disorders

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Drug Safety

• Publication date

  1999-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00002018-199920060-00006PMID 10392669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial.

  2020cited by this paper
• NSAID-Induced Gastrointestinal Damage

  2012cited by this paper
• Gastric adaptation occurs with aspirin administration in man

  2005cited by this paper
• Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

  1999cited by this paper
• Management of Peptic Ulcer Disease

  1998cited by this paper
• Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.

  1998cited by this paper
• NSAIDs and Helicobacter pylori: therapeutic options.

  1998cited by this paper
• Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production.

  1998cited by this paper
• Clinical Endoscopic Evaluation of the Gastroduodenal Tolerance to (R)‐ Ketoprofen, (R)‐ Flurbiprofen, Racemic Ketoprofen, and Paracetamol: A Randomized, Single‐Blind, Placebo‐Controlled Trial

  1998cited by this paper
• Recent considerations in nonsteroidal anti-inflammatory drug gastropathy.

  1998cited by this paper
• Effect of nitric oxide-releasing aspirin derivative on gastric functional and ulcerogenic responses in rats: comparison with plain aspirin.

  1998cited by this paper
• Effects of Cyclooxygenase-2 Selective and Nitric Oxide-Releasing Nonsteroidal Antiinflammatory Drugs on Mucosal Ulcerogenic and Healing Responses of the Stomach

  1998cited by this paper
• Clinical science of Helicobacter pylori infection: ulcers and NSAIDs.

  1998cited by this paper
• The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs.

  1998cited by this paper
• Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects.

  1998cited by this paper
• New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.

  1998cited by this paper
• Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.

  1998cited by this paper
• Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans.

  1998cited by this paper
• Omeprazole and sucralfate in the treatment of NSAID‐induced gastric and duodenal ulcer

  1998cited by this paper
• Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis.

  1998cited by this paper
• Role of cyclooxygenase-2 in the healing of gastric ulcers in rats.

  1998cited by this paper
• A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.

  1998cited by this paper
• Peptic ulcer therapy with cimetidine versus tripotassium dicitrato bismuthate in rheumatoid arthritis patients undergoing chronic NSAID treatment

  1998cited by this paper
• Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in rats

  1998cited by this paper
• Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.

  1998cited by this paper
• Preclinical Enantioselective Pharmacology of (R)‐ and (S)‐ Ketorolac

  1998cited by this paper
• Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs

  1998cited by this paper
• Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: role of neutrophils.

  1997cited by this paper
• Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: role of neutrophils.

  1997cited by this paper
• Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia

  1997cited by this paper
• Outcome of specific COX-2 inhibition in rheumatoid arthritis.

  1997cited by this paper
• The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome.

  1997cited by this paper
• COX-1 and COX-2 tissue expression: implications and predictions.

  1997cited by this paper
• Mechanism of action of anti-inflammatory drugs.

  1997cited by this paper
• Peptic ulcer bleeding in the elderly: relative roles ofHelicobacter pylori and non-steroidal anti-inflammatory drugs

  1997cited by this paper
• New perspectives for nonsteroidal antiinflammatory therapy.

  1997cited by this paper
• Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.

  1997cited by this paper
• Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor

  1997cited by this paper
• New perspectives for nonsteroidal antiinflammatory therapy.

  1997cited by this paper
• Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.

  1997cited by this paper
• Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.

  1996cited by this paper
• Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial.

  1996cited by this paper
• Early pathogenic events in NSAID-induced gastrointestinal damage.

  1996cited by this paper
• Prostaglandin endoperoxide H synthases-1 and -2.

  1996cited by this paper
• Histological features do not define NSAID-induced gastritis.

  1996cited by this paper
• Prevention of Nonsteroidal Anti-inflammatory Drug—Induced Gastrointestinal Mucosal Injury: A Meta-analysis of Randomized Controlled Clinical Trials

  1996cited by this paper
• Therapy of NSAIDs-induced gastropathy.

  1996cited by this paper
• Gastroduodenal tolerability of highly specific cyclo-oxygenase-2 inhibitor.

  1996cited by this paper
• Role of vacA and the cagA locus of Helicobacter pylori in human disease.

  1996cited by this paper
• Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study.

  1996cited by this paper
• Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2*

  1996cited by this paper
• Cyclooxygenase 1 and 2 in rheumatic disease: implications for nonsteroidal anti-inflammatory drug therapy.

  1996cited by this paper
• Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

  1996cited by this paper
• Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation.

  1996cited by this paper
• Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.

  1996cited by this paper
• Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand.

  1996cited by this paper
• Mechanism of action of anti-inflammatory drugs.

  1996cited by this paper
• Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand.

  1996cited by this paper
• Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs

  1995cited by this paper
• Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword.

  1995cited by this paper
• Guidelines for the medical management of osteoarthritis. II: Osteoarthritis of the knee

  1995cited by this paper
• Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II

  1995cited by this paper
• Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.

  1995cited by this paper
• Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats.

  1995cited by this paper
• Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology.

  1995cited by this paper
• Misoprostol Dosage in the Prevention of Nonsteroidal Anti-inflammatory Drug-Induced Gastric and Duodenal Ulcers: A Comparison of Three Regimens

  1995cited by this paper
• Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology.

  1995cited by this paper
• Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

  1995cited by this paper
• Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.

  1994cited by this paper
• Non-steroidal anti-inflammatory drugs: how do they damage the gut?

  1994cited by this paper
• Review article: controversies in NSAID‐induced gastroduodenal damage‐do they matter?

  1994cited by this paper
• Ranitidine in the prevention of non‐steroidal anti‐inflammatory drug‐associated gastric and duodenal ulceration in arthritic patients

  1994cited by this paper
• Gastrointestinal complications of nonsteroidal anti-inflammatory drugs: prophylactic and therapeutic strategies.

  1994cited by this paper
• Additive effect of combined naproxen and paracetamol in rheumatoid arthritis.

  1993cited by this paper
• A reevaluation of aspirin therapy in rheumatoid arthritis.

  1993cited by this paper
• Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.

  1993cited by this paper
• Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines.

  1993cited by this paper
• Gastric ulceration: critical events at the neutrophil--endothelium interface.

  1993cited by this paper
• Adverse effects of low‐dose aspirin in a healthy elderly population

  1993cited by this paper
• Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs.

  1993cited by this paper
• Nonsteroidal anti-inflammatory drugs--the clinical dilemmas.

  1992cited by this paper
• Epidemiology and economics of NSAID-induced gastropathy.

  1992cited by this paper
• A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis.

  1992cited by this paper
• Misoprostol Compared with Sucralfate in the Prevention of Nonsteroidal Anti-inflammatory Drug-induced Gastric Ulcer: A Randomized, Controlled Trial

  1991cited by this paper
• Nonsteroidal anti-inflammatory drugs and peptic ulcer disease.

  1991cited by this paper
• Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group.

  1991cited by this paper
• Upper gastrointestinal tract hemorrhage.

  1991cited by this paper
• Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis.

  1991cited by this paper
• Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs.

  1991cited by this paper
• Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.

  1991cited by this paper
• Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

  1991cited by this paper
• Helicobacter pylori infection and gastroduodenal injury by non-steroidal anti-inflammatory drugs.

  1991cited by this paper
• A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke.

  1991cited by this paper
• Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers.

  1991cited by this paper
• Gastroduodenal mucosal defense

  1991cited by this paper
• Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.

  1991cited by this paper
• Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice.

  1990cited by this paper
• The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.

  1990cited by this paper
• Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.

  1989cited by this paper
• Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.

  1989cited by this paper

• The therapeutic effect of different cumin essential oil fractions against gastric ulcer in rats.

  2024cites this paper
• Analysis of NSAIDs in Rat Plasma Using 3D-Printed Sorbents by LC-MS/MS: An Approach to Pre-Clinical Pharmacokinetic Studies

  2023cites this paper
• The effects of dragon fruit (Hylocereus polyrhizus) extract on indomethacin-induced stomach ulcer in rats.

  2022cites this paper
• Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study.

  2021cites this paper
• The comparative effects of oral famotidine and lansoprazole in prophylaxis of aspirin induced peptic ulcer in albino rat

  2021cites this paper
• Effects of the diphenylheptane extract of Alpinia officinarum rhizomes on ethanol-induced gastric ulcers in mice

  2021cites this paper
• Can aprepitant used for nausea and vomiting be good gastrointestinal complaints?

  2020cites this paper
• The Protective Roles of Butein on Indomethacin Induced Gastric Ulcer in Mice.

  2020cites this paper
• Perioperative Nonsteroidal Anti-inflammatory Drugs (NSAID) Administration and Acute Kidney Injury (AKI) in Major Gastrointestinal Surgery

  2020cites this paper
• Co-Administration of Nonsteroidal Ant-Inflammtory Drugs and Gastropotective Drugs in Orthopaedic Out Patient Department of a University Hospital in Kashmir

  2016cites this paper
• Inhibiting renin angiotensin system in rate limiting step by aliskiren as a new approach for preventing indomethacin induced gastric ulcers.

  2016cites this paper
• Gastroprotective Effect of Geopropolis from Melipona scutellaris Is Dependent on Production of Nitric Oxide and Prostaglandin

  2015cites this paper
• The Protective Role of Aegle Marmelos on Aspirin–Induced Gastro-Duodenal Ulceration in Albino Rat Model: A Possible Involvement of Antioxidants

  2012cites this paper
• Non-Steroidal Anti-Inflammatory Drugs and Gastroprotection with Proton Pump Inhibitors

  2012cites this paper
• Esomeprazole for the Management of Upper Gastrointestinal Symptoms in Patients Who Require NSAIDs

  2009cites this paper
• Celecoxib versus a Non-Selective NSAID Plus Proton-Pump Inhibitor

  2006cites this paper
• An In-Depth Look : THE GASTRIC MUCOSAL BARRIER IN DOGS

  2006cites this paper
• The Use of Gastroprotectants in Treating Gastric Ulceration in Dogs

  2006cites this paper
• Letters to the Editor

  2006cites this paper
• Determinants of gastro-protective drugs co-prescription during treatment with nonselective NSAIDs: a prospective survey of 2197 patients recruited in primary care.

  2005cites this paper
• Postoperative pain management in obstetric anesthesia--new challenges and solutions.

  2004cites this paper
• Fármacos antiinflamatorios no esteroideos y gastroprotección

  2004cites this paper
• Prescripciones inapropiadas en ancianos institucionalizados

  2004cites this paper
• Predicting the risk for gastrointestinal toxicity in patients taking NSAIDs: The Gastrointestinal Toxicity Survey

  2004cites this paper
• Pharmacoeconomic Modeling of Prior-Authorization Intervention for COX-2 Specific Inhibitors in a 3-Tier Copay Plan

  2003influential citation
• NSAIDs, gastroprotection and cyclo‐oxygenase‐II‐selective inhibitors *

  2003cites this paper
• Practical Prescribing Guidelines for Rheumatoid Arthritis

  2003cites this paper
• Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional nonsteroidal antiinflammatory drugs combined with omeprazole.

  2002cites this paper
• Enteric coating of mycophenolate sodium: a rational approach to limit topical gastrointestinal lesions and extend the therapeutic index of mycophenolate.

  2001cites this paper
• Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in France.

  2001cites this paper
• Endoscopic evaluation of the gastrotolerance of short‐term antalgic treatment with low dose k‐diclofenac: a comparison of ibuprofen and aspirin

  2001cites this paper
• Preventing gastrointestinal complications of NSAIDs

  2001cites this paper
• BÖBREK TRANSPLANTASYONLU HASTALARDA GASTROİNTESTİNAL SİSTEME AİT KOMPLİKASYONLAR

  2001cites this paper
• Tolérance gastro-intestinale des anti-inflammatoires non-stéroïdiens

  2000cites this paper
• [Gastrointestinal tolerance of nonsteroidal anti-inflammatory agents].

  2000cites this paper
• Postmarketing surveillance of proton pump inhibitors in perspective: the case of Lansoprazole

  2000cites this paper